# Weeks in an isolation room: what a trial says about virtual reality in bone marrow transplant
URL: https://rver.pt/blog/transplante-medula-isolamento-realidade-virtual/en/
Date: 12 November 2026

A bone marrow transplant often means weeks in a closed room, with limited visits and a body under heavy strain. It is one of the hardest hospital stays there is. A trial published in 2026 tested whether virtual reality could help people get through it.

## A stay measured in weeks

In haematopoietic stem cell transplant, what many still call a bone marrow transplant, there is a phase when the patient's defences drop to almost nothing. To protect them from infection the stay often happens in protective isolation: a closed room, restricted visits, everything that comes in is controlled. It can last weeks.

Anxiety, feeling trapped and lack of stimulation are common complaints. And there is little to offer that fits in a room like that.

## The BMT-VR trial

In August 2026 the *Journal of the National Comprehensive Cancer Network* published a pilot randomised trial run at Massachusetts General Hospital in Boston between December 2022 and April 2024 ([summary in ONS Voice](https://www.ons.org/publications-research/voice/news-views/10-2026/psychosocial-vr-intervention-may-improve-mental-health-hsct-recipients)).

- 80 adults admitted for transplant took part, 39 in the VR group and 41 with usual care.
- The programme had six VR modules, designed for the patient to use alone, with coping techniques drawn from cognitive behavioural therapy, mindfulness and positive psychology.
- Patients were encouraged to do two modules a week during the stay. About 69% completed all six.

## What they found

Four weeks after transplant, the VR group had:

- better quality of life (108.2 vs 96.8 on the scale used);
- less anxiety (3.6 vs 5.3);
- more coping skills and more confidence in their own ability to cope.

Depressive and post-traumatic stress symptoms and physical symptom burden were similar in both groups at four weeks. Over 24 weeks, the authors report more favourable values in the VR group.

## The caveats

The authors themselves call it a pilot. It was run at one centre, with a not very diverse population, and the programme was only available in English. It shows the approach is feasible and that patients use it, and it gives positive signals. It is not enough to say it works everywhere.

There are also registered trials testing virtual reality combined with hypnosis in haematology patients in protective isolation rooms, which shows more teams are asking the same question.

## What this says about the isolation room

The programme in this trial was psychoeducational: it taught strategies. That is different from taking the patient to another place for a few minutes. But both answer the same problem, which is the patient's world shrinking to four walls for weeks.

A standalone headset, with no cables and no internet, can go into an isolation room under the same hygiene rules as any other shared equipment. We explained cleaning in [hygiene and equipment safety](/blog/higiene-seguranca-equipamento-realidade-virtual/en/). And we have written about [virtual reality during chemotherapy](/blog/realidade-virtual-quimioterapia-oncologia/en/), which many of these patients go through before transplant.

RVer is used by clinical teams in oncology and long-stay contexts, always with a professional leading the session.

Q: Can virtual reality be used in a protective isolation room?
A: A standalone headset can, as long as it follows the unit's hygiene and disinfection rules, like any shared equipment.

Q: Does the BMT-VR trial prove virtual reality works in transplant?
A: No. It is a single-centre pilot with positive signals on quality of life and anxiety. Larger studies are needed.